Stockscreener 앱 받기
5.39
0.56%
0.03
전일 마감가:
$5.36
열려 있는:
$5.41
하루 거래량:
30,300
Relative Volume:
2.59
시가총액:
$193.82M
수익:
-
순이익/손실:
$-25.50M
주가수익비율:
-7.00
EPS:
-0.77
순현금흐름:
$-30.10M
1주 성능:
+0.56%
1개월 성능:
+0.58%
6개월 성능:
+44.89%
1년 성능:
+117.34%
1일 변동 폭
$5.30
$5.41
1주일 범위
$5.30
$5.4793
52주 변동 폭
$2.20
$6.1999
Eupraxia Pharmaceuticals Inc Stock (EPRX) Company Profile
EPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EPRX
Eupraxia Pharmaceuticals Inc
|
5.39 | 192.74M | 0 | -25.50M | -30.10M | -0.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-26 | 개시 | H.C. Wainwright | Buy |
| 2025-06-16 | 개시 | Canaccord Genuity | Speculative Buy |
| 2025-02-21 | 개시 | Craig Hallum | Buy |
| 2024-11-14 | 개시 | Rodman & Renshaw | Buy |
Eupraxia Pharmaceuticals Inc 주식(EPRX)의 최신 뉴스
Published on: 2025-09-07 01:20:28 - Newser
How to manage a losing position in Eupraxia Pharmaceuticals Inc.July 2025 Momentum & Short-Term High Return Strategies - Newser
Leading vs lagging indicators on Eupraxia Pharmaceuticals Inc. performanceMarket Performance Summary & Daily Momentum Trading Reports - Newser
Understanding Eupraxia Pharmaceuticals Inc.’s price movement2025 Institutional Moves & Weekly Breakout Stock Alerts - Newser
How to interpret RSI for Eupraxia Pharmaceuticals Inc. stockWeekly Market Report & Daily Chart Pattern Signal Reports - Newser
Is Eupraxia Pharmaceuticals Inc. stock a growth or value play2025 Valuation Update & High Yield Stock Recommendations - Newser
Quant Funds Rotate Into Eupraxia Pharmaceuticals Inc. StockBull Run & Expert Verified Stock Movement Alerts - beatles.ru
Will Eupraxia Pharmaceuticals Inc. benefit from sector rotationJuly 2025 Closing Moves & Safe Entry Momentum Tips - خودرو بانک
Can Eupraxia Pharmaceuticals Inc. outperform under higher oil pricesQuarterly Investment Review & Safe Capital Investment Plans - خودرو بانک
Will Eupraxia Pharmaceuticals Inc. benefit from seasonalityJuly 2025 Action & Real-Time Stock Price Movement Reports - خودرو بانک
What is the earnings history of Eupraxia Pharmaceuticals Inc.July 2025 EndofMonth & Real-Time Volume Surge Alerts - خودرو بانک
Will Eupraxia Pharmaceuticals Inc. benefit from rate cuts2025 Dividend Review & Low Risk High Win Rate Picks - خودرو بانک
How to build a custom watchlist for Eupraxia Pharmaceuticals Inc.Portfolio Risk Summary & Reliable Price Action Trade Plans - Newser
Is Eupraxia Pharmaceuticals Inc. stock entering bullish territoryEarnings Risk Summary & Reliable Trade Execution Plans - Newser
Published on: 2025-09-04 21:46:56 - Newser
Momentum divergence signals in Eupraxia Pharmaceuticals Inc. chartWeekly Profit Recap & Stock Market Timing Techniques - Newser
Should I average down on Eupraxia Pharmaceuticals Inc. stock2025 Dividend Review & Technical Entry and Exit Tips - خودرو بانک
Earnings visualization tools for Eupraxia Pharmaceuticals Inc.July 2025 PreEarnings & Precise Buy Zone Identification - Newser
Eupraxia Pharmaceuticals Inc. stock daily chart insightsStop Loss & Verified Momentum Stock Watchlist - Newser
Eupraxia Pharmaceuticals Inc. stock outlook for YEAREarnings Risk Summary & Community Consensus Picks - Newser
Can Eupraxia Pharmaceuticals Inc. hit a new high this monthJuly 2025 Technicals & Daily Entry Point Alerts - Newser
Does Eupraxia Pharmaceuticals Inc. show high probability of reboundJuly 2025 PostEarnings & Weekly High Return Opportunities - Newser
Eupraxia Pharmaceuticals Inc. stock trend outlook and recovery pathJuly 2025 Volume & Trade Opportunity Analysis Reports - Newser
Will Eupraxia Pharmaceuticals Inc. outperform during market ralliesJuly 2025 Sector Moves & Weekly Setup with ROI Potential - خودرو بانک
Bull Bear: Can Eupraxia Pharmaceuticals Inc. maintain its current growth rateQuarterly Profit Report & AI Enhanced Trading Alerts - خودرو بانک
Does Eupraxia Pharmaceuticals Inc. stock benefit from AI growthDividend Hike & AI Based Trade Execution Alerts - خودرو بانک
Should you sell your Eupraxia Pharmaceuticals stock? - Cantech Letter
Smart tools for monitoring Eupraxia Pharmaceuticals Inc.’s price actionInsider Selling & AI Powered Trade Plan Recommendations - Newser
Is Eupraxia Pharmaceuticals Inc. trending in predictive chart modelsWeekly Trade Summary & Real-Time Buy Signal Notifications - Newser
Signal strength of Eupraxia Pharmaceuticals Inc. stock in tech scannersMarket Volume Report & Safe Entry Point Alerts - Newser
Market reaction to Eupraxia Pharmaceuticals Inc.’s recent newsJuly 2025 Big Picture & Smart Swing Trading Alerts - Newser
Published on: 2025-09-03 02:09:55 - Newser
What technical models suggest about Eupraxia Pharmaceuticals Inc.’s comebackDollar Strength & Stepwise Entry and Exit Trade Signals - Newser
Is Eupraxia Pharmaceuticals Inc. in a bullish channel2025 Support & Resistance & Momentum Based Trading Ideas - خودرو بانک
First Set of 1-Year Clinical Results from RESOLVE Trial in - GlobeNewswire
Eupraxia Pharmaceuticals shares rise 10.91% after-hours following positive 1-year clinical results from RESOLVE trial. - AInvest
Sentiment Recap: Will Eupraxia Pharmaceuticals Inc. outperform during market ralliesMarket Volume Report & AI Driven Stock Movement Reports - خودرو بانک
Earnings Report: Is Eupraxia Pharmaceuticals Inc. in a bullish channel2025 Historical Comparison & Expert Curated Trade Setups - خودرو بانک
Research Solutions, Inc. shares rise 2.64% intraday after Eupraxia Pharmaceuticals Inc. reported positive clinical trial results. - AInvest
Update Recap: Will Eupraxia Pharmaceuticals Inc. benefit from rate cutsLayoff News & Weekly High Conviction Ideas - خودرو بانک
Published on: 2025-09-02 10:22:34 - Newser
Eupraxia Pharmaceuticals Reports Promising 1-Year Results for EoE Treatment - TipRanks
One-Year Treatment Success: Eupraxia's Once-Yearly EoE Drug Maintains 67% Patient Remission in Clinical Trial - Stock Titan
Published on: 2025-09-02 06:56:07 - Newser
What are the future prospects of Eupraxia Pharmaceuticals Inc.Swing Trade & Intraday High Probability Alerts - خودرو بانک
Will Eupraxia Pharmaceuticals Inc. price bounce be sustainableJuly 2025 Market Mood & Risk Controlled Daily Trade Plans - Newser
Eupraxia Pharmaceuticals Inc (EPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):